Innovation at the speed of life.

 

ESCMID GLOBAL 2026

Scientific Symposia Program

Featuring expert‑led sessions from Danaher, Cepheid and Beckman Coulter

Advance diagnostic stewardship with sessions that connect testing strategy to clinical action. Hear expert perspectives on choosing the right modality, integrating results into workflows, and improving cost and care outcomes, including discussions spanning multiplex, NGS, and metagenomics

 

DANAHER INTEGRATED SYMPOSIUM

From Emerging Threats to Diagnostic Breakthroughs:  A Strategic Look Ahead in AMR

Sunday, April 19th, 2026, 08:30 - 10:00 am

A1-5 Hall​

08:30 AM

Welcome and Introduction

Organiser-Appointed Chair: Ephraim Tsalik, MD, MHS, Ph.D. Vice President and Chief Science Officer - Infectious Disease & Acute Care, Danaher, Adjunct Associate Professor, Duke University School of Medicine, Staff Physician, Durham VA Health Care System, Durham, USA

ESCMID-appointed Chair: Assoc. Pr. Dr. Onur Karatuna, Lead Scientist, EUCAST Development Laboratory, Clinical Microbiology Växjö hospital, Växjö, Swedenat EUCAST Development Laboratory Clinical Microbiology, Medical Microbiologist Växjö hospital, Växjö, Sweden

 

08:40 AM

Talk 1: From MRSA to C. auris: Lessons Learned Across Two Decades of MDRO Screening
Dr. David R. Jenkins, BSc MBBS MSc FRCPath, Consultant Medical Microbiologist at University Hospitals of Leicester NHS Trust, UK

 

08:55 AM

Talk 2: Recent Advances in Molecular Diagnostics for the Rapid Detection of Antibiotic Resistances in Gram Negatives
Pr. Patrice Nordmann, MD, Ph.D. Head, Medical and Molecular Microbiology Unit, Emerging Antibiotic Resistance at Swiss National Reference Center for Emerging Antibiotic Resistance, Switzerland

 

09:10 AM

Talk 3: Beyond Diagnostic Accuracy: Understanding Clinician Behaviour to Improve Biomarker- Guided Antibiotic Decisions
Pr. Enitan Carrol, Professor of Paediatric Infection at University of Liverpool, UK

 

09:25 AM

Talk 4: Rapid MIC Testing: Fact or Fiction

Dr. Romney Humphries, Ph.D, D(ABMM), M(ASCP), Executive Medical Director, Pathology & Lab Medicine and Vice Chair, Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, Nashville Tennessee, USA

 

09:40 AM

Panel Discussion & QA

 

 

CEPHEID INTEGRATED SYMPOSIUM

Precision vs Power: Smarter Panels and the Path to Metagenomics

Monday, April 20th, 2026, 8:30 - 10:00 am

A1-2 Hall​

08:30 AM

Welcome and Introduction

Organiser-appointed Chair: Pr. Christophe Rodriguez, PharmD, Ph.D. Head of the GenoBioMics Platform, Metagenomic Reference Laboratory, Henri Mondor Hospital, Créteil, France

ESCMID-appointed Chair: Pr. Maurizio Sanguinetti, Professor of Microbiology and Laboratory Director, Fondazione Policlinico Universitario A. gemelli, Roma, Italy 

 

08:35 AM

Talk 1: Pathways to Better Care: Diagnostic Stewardship and Future Innovation

Dr. Connie Savor, MD, MBA, Chief Medical Officer, Cepheid, Sunnyvale, USA

 

08:50 AM

Talk 2 : Taking Action from Respiratory Pathogen Testing: Real World Lessons

Dr. Cristina Russo, Head of Virology and Mycobacteria Unit, Bambino Gesù Pediatric Hospital, Rome, Italy

 

09:10 AM

Talk 3: Multiplex Molecular Testing for Diagnosis of GI infections: an American Commercial Reference Laboratory Experience

Dr. Gerald A. Capraro, Ph.D. D(ABMM), Technical Director, Routine and Esoteric Microbiology, Labcorp, Burlington, USA

 

09:30 AM

Talk 4: Pathogen Genomics: Redefining Infection Management for Modern Healthcare

Dr. James Price, Associate Professor in Infection, Department of Global Health and Infection, Brighton and Sussex Medical School, UK, Brighton, UK

 

09:50 AM

Panel Discussion & QA

 

Add the breakfast symposia to your calendar and download the full scientific programme

Explore scientific posters and in‑booth presentations presenting clinical data, health‑economic analyses, and real‑world evidence across selected areas of infectious disease diagnostics. (Breakfast will be provided)

I would like to be part of the Cepheid Community and I understand and consent to receive information about products and services, invitations to virtual and in-person events such as workshops and webinars and educational content from Cepheid and similar information from Cepheid’s affiliates and representatives.

*required fields
Cepheid respects your privacy, and values the relationship with our customers, partners, and associates. Your personal data may be processed by Cepheid, its affiliates, representatives and other Danaher companies for business and marketing purposes. You can review Cepheid Privacy Policy online for additional information on your rights and how we use and share personal data we collect on our websites and other channels. Your consent to receiving Cepheid news can be withdrawn at any time. Building a relationship of trust is important to us and we will happily help with any questions on your personal data processing addressed to Privacy.officer@cepheid.com

CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.

About Danaher

Danaher is a leading global life sciences and diagnostics innovator, helping to solve many of the world’s most important health challenges. Across Danaher’s ecosystem of industry-leading businesses, we’re committed to improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow.

 

Our diagnostics businesses, including Beckman Coulter Diagnostics and Cepheid, are shaping the future of health by pushing the boundaries of what’s possible for point-of-care and lab solutions. We work at the pace of change to develop solutions that put quality, productivity, automation, and scale first, to improve patient outcomes around the world.

 

Our biotechnology business, led by Cytiva, delivers researchers and biopharmaceutical companies the expertise, tools, and services they need to develop and commercialize life-changing therapeutics.

 

Together, we drive precision diagnostics and transformative therapies, improving health outcomes globally.

©2026 Cepheid. All Rights Reserved.